Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 1, 2006, Pages 362-364

  Zhao, Xilin ^a   Malik, Muhammad ^a   Chan, Nymph ^a   Drlica Wagner, Alex ^a   Wang, Jian Ying ^a   Li, Xinying ^a   Drlica, Karl ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; DNA B; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; DNA REPLICATION; DRUG MECHANISM; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; TEMPERATURE SENSITIVITY;

ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CHLORAMPHENICOL; DNA HELICASES; DNA REPLICATION; DNAB HELICASES; ESCHERICHIA COLI; MUTATION; QUINOLONES; TEMPERATURE;

EID: 29944439813     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.1.362-364.2006     Document Type: Article

References (26)

1. Caruthers, J. M., and D. B. McKay. 2002. Helicasc structure and mechanism. Curr. Opin. Struct. Biol. 12:123-133.
2. Chen, C.-R., M. Malik, M. Snyder, and K. Drlica. 1996. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J. Mol. Biol. 258:627-637.
3. D'Arpa, P., C. Beardmore, and L. F. Liu. 1990. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 50:6919-6924.
4. Deitz, W. H., T. M. Cook, and W. A, Goss. 1966. Mechanism of action of nalidixic acid on Escherichia coli. III. Conditions required for lethality. J. Bacteriol. 91:768-773.
5. Drlica, K., and D. C. Hooper. 2003. Mechanisms of quinolone action, p. 19-40. In D. C. Hooper and E. Rubinstein (ed.), Quinolone antimicrobial agents, 3rd ed. American Society for Microbiology, Washington, D.C.
6. Fangman, W., and A. Novick. 1968. Characterization of two bacterial mutants with temperature-sensitive synthesis of DNA. Genetics 60:1-17.
7. Goss, W. A., W. H. Deitz, and T. M. Cook. 1964. Mechanism of action of nalidixic acid on Escherichia coli. J. Bacteriol. 88:1112-1118.
8. Goss, W. A., W. H. Deitz, and T. M. Cook. 1965. Mechanism of action of nalidixic acid on Escherichia coli. II. Inhibition of deoxyribonucleic acid synthesis. J. Bacteriol. 89:1068-1074.
9. Hiasa, H., D. Yousef, and K. Marians. 1996. DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex. J. Biol. Chem. 271:26424-26429.
10. Jaktaji, R. P., and R. G. Lloyd. 2003. PriA supports two distinct pathways for replication restart in UV-irradiated Escherichia coli cells. Mol. Microbiol. 47:1091-1100.
11. LeBowitz, J. H., and R. McMacken. 1986. The Escherichia coli dnaB replication protein is a DNA helicase. J. Biol. Chem. 261:4738-4748.
12. Lewin, C., B. Howard, and J. Smith. 1991. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase. J. Med. Microbiol. 34:19-22.
13. Manes, S. H., G. J. Pruss, and K. Drlica. 1983. Inhibition of RNA synthesis by oxolinic acid is unrelated to average DNA supercoiling. J. Bacteriol. 155:420-423.
14. Miller, J. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
15. Pohlhaus, J., and K. N. Kreuzer. 2005. Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo. Mol. Microbiol. 56:1416-1429.
16. Sandler, S. J., and K. J. Marians. 2000. Role of PriA in replication fork reactivation in Escherichia coli. J. Bacteriol. 182:9-13.
17. Shea, M., and H. Hiasa. 1999. Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes. J. Biol. Chem. 274:22747-22754.
18. Smith, J. T., and C. S. Lewin. 1988. Chemistry and mechanisms of action of the quinolone antibacterials, p. 23-82. In V. T. Andriole (ed.), The quinolones, vol. 1. Academic Press, San Diego, Calif.
19. Snyder, M., and K. Drlica. 1979. DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid. J. Mol. Biol. 131:287-302.
20. Sternglanz, R., S. DiNardo, K. A. Voelkel, Y. Nishimura, Y. Hirota, A. K. Becherer, L. Zumstein, and J. C. Wang. 1981. Mutations in the gene coding for Escherichia coli DNA topoisomerase I affecting transcription and transposition. Proc. Natl. Acad. Sci. USA 78:2747-2751.
21. Tsao, Y.-P., A. Russe, G. Nyamuswa, R. Silber, and L. F. Liu. 1993. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res. 53:5908-5914.
22. Wall, J. D., and P. D. Harriman. 1974. Phage Pl mutants with altered transducing abilities for Escherichia coli. Virology 59:532-544.
23. Wentzell, L., and A. Maxwell. 2000. The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex. J. Mol. Biol. 304:779-791.
24. Willmott, C. J. R., S. E. Critchlow, I. C. Eperon, and A. Maxwell. 1994. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. J. Mol. Biol. 242:351-363.
25. Yang, S.-W., A. B. Burgin, B. N. Huizenga, C. A. Robertson, K. C. Yao, and H. A. Nash. 1996. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc. Natl. Acad. Sci. USA 93:11534-11539.
26. Zhao, X., C. Xu, J. Domagala, and K. Drlica. 1997. DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance. Proc. Natl. Acad. Sci. USA 94:13991-13996.